LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review

Female-related cancers, including breast, ovarian, endometrial, and cervical malignancies, are among the most prevalent and clinically significant health challenges worldwide. Their development involves a complex interplay of genetic mutations, environmental factors, lifestyle influences, and therapeutic interventions. Long non-coding RNAs (lncRNAs) have emerged as critical regulators in these cancers, modulating epigenetic mechanisms, transcriptional programs, and post-transcriptional processes. Aberrant lncRNA expression promotes tumor initiation, drives progression and metastasis, and facilitates epithelial-mesenchymal transition (EMT) and angiogenesis. Among these, colon cancer-associated transcript 2 (CCAT2) has been identified as an oncogenic lncRNA across multiple tumor types. CCAT2 primarily activates the Wnt/β-catenin signaling pathway, enhancing β-catenin transcriptional activity and upregulating downstream targets such as MYC and cyclin D1, which are essential for cancer cell proliferation and survival. Despite growing evidence of its oncogenic role, the specific contribution of CCAT2 to female-related cancers remains incompletely understood. This study systematically reviews recent findings on CCAT2’s role in the development and progression of breast, ovarian, endometrial, and cervical cancers, elucidates the underlying molecular mechanisms, and evaluates its potential as a diagnostic and prognostic biomarker. Furthermore, the translational potential of CCAT2 as a therapeutic target is discussed, highlighting opportunities for improving clinical outcomes in these malignancies.

• Publication year

  2026

• Venue

  Clinical and Experimental Medicine (Testo stampato)

• Publication date

  2026-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10238-026-02040-7PMID 41655184PMCID 12886321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts

  2025cited by this paper
• Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis

  2025cited by this paper
• Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review

  2025cited by this paper
• CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies

  2025cited by this paper
• Involvement of lncRNA in cancer diagnosis and prognosis and clinical implications

  2025cited by this paper
• The role of NETosis in breast cancer: mechanistic insights and biomarker potential

  2025cited by this paper
• Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancer

  2025cited by this paper
• LncRNA-Mediated miR-145 Sponging Drives FN1 and CCND1 Expression: Prognostic and Therapeutic Targets in NSCLC

  2025cited by this paper
• Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies.

  2025cited by this paper
• lncRNA CCAT2 Protects Against Cardiomyocyte Injury After Myocardial Ischemia/Reperfusion by Regulating BMI1 Expression.

  2024cited by this paper
• Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons

  2024cited by this paper
• Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer

  2024cited by this paper
• Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression

  2024cited by this paper
• The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers

  2024cited by this paper
• Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution

  2023cited by this paper
• Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry.

  2023cited by this paper
• An Overview of Endometrial Cancer with Novel Therapeutic Strategies

  2023cited by this paper
• Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers

  2023cited by this paper
• Long non-coding RNAs: definitions, functions, challenges and recommendations

  2023cited by this paper
• CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells.

  2022cited by this paper
• LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation

  2022cited by this paper
• Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women

  2022cited by this paper
• Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers

  2022influential reference
• Effect of long noncoding RNA CCAT2 on drug sensitivity to 5‐fluorouracil of breast cancer cells through microRNA‐145 meditated by p53

  2022cited by this paper
• Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

  2022cited by this paper
• Single Nucleotide Polymorphisms of EXOC1, BCL2, CCAT2, and CARD8 Genes and Susceptibility to Cervical Cancer in the Northern Chinese Han Population

  2022cited by this paper
• The Role of Long Non-Coding RNA CCAT1 and SNHG14 in Activation of Some Protein-Coding Genes Associated with the Development of Ovarian Cancer

  2022cited by this paper
• lncRNA-CCAT2 Reduces the Drug Resistance of Ovarian Cancer Cells

  2022cited by this paper
• Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis

  2022cited by this paper
• Circulating LncRNAs landscape as potential biomarkers in breast cancer

  2022cited by this paper
• Long non-coding RNA H19 correlates with unfavorable prognosis and promotes cell migration and invasion in ovarian cancer.

  2021cited by this paper
• The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions

  2021cited by this paper
• Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer

  2021cited by this paper
• Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis

  2021influential reference
• Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts

  2021cited by this paper
• Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders

  2021cited by this paper
• Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the β-catenin/WISP1 signaling pathway

  2021cited by this paper
• Altered expression of CCAT1 and CCAT2 lncRNAs in autism spectrum disorder

  2021cited by this paper
• In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis

  2021cited by this paper
• Functional annotation of lncRNA in high-throughput screening

  2021cited by this paper
• Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries

  2021cited by this paper
• Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects.

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth

  2021cited by this paper
• Biological functions and clinical applications of exosomal long non‐coding RNAs in cancer

  2020influential reference
• Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway

  2020influential reference
• CCAT2 contributes to progression and treatment resistance of thyroid carcinoma.

  2020cited by this paper
• Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer

  2020influential reference
• The Long Noncoding RNA CCAT2 induces chromosomal instability through BOP1 - AURKB signaling.

  2020cited by this paper
• Knockdown of long non-coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β-catenin pathway

  2020cited by this paper
• Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma

  2020cited by this paper
• A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases

  2020influential reference
• LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424

  2020cited by this paper
• [Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis].

  2020influential reference
• lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424

  2020cited by this paper
• Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2

  2020influential reference
• Long non-coding RNA CCAT2 promotes oncogenesis in triple negative breast cancer by regulating stemness of cancer cells.

  2020cited by this paper
• Therapeutic targeting of miRNA-216b in cancer.

  2020cited by this paper
• CD40 induces renal cell carcinoma-specific differential regulation of TRAF proteins, ASK1 activation and JNK/p38-mediated, ROS-dependent mitochondrial apoptosis

  2019cited by this paper
• The emerging role of WISP proteins in tumorigenesis and cancer therapy

  2019cited by this paper
• The current state and future directions of RNAi-based therapeutics

  2019cited by this paper
• Tumor‐derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy

  2019cited by this paper
• Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges

  2019cited by this paper
• mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model

  2019cited by this paper
• The lncRNA CCAT2 rs6983267 G allele is associated with decreased susceptibility to recurrent miscarriage

  2019influential reference
• Benefits and limitations of genome-wide association studies

  2019cited by this paper
• Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels

  2019cited by this paper
• Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

  2018cited by this paper
• Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

  2018cited by this paper
• Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer.

  2018influential reference
• Role of lncRNAs in aging and age‐related diseases

  2018cited by this paper
• High-throughput functional analysis of lncRNA core promoters elucidates rules governing tissue specificity

  2018cited by this paper
• The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population

  2018influential reference
• Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.

  2018cited by this paper
• MicroRNA-216b inhibits heat stress-induced cell apoptosis by targeting Fas in bovine mammary epithelial cells

  2018cited by this paper
• Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance

  2018cited by this paper
• Long non-coding RNA MALAT1 suppresses breast cancer metastasis

  2018cited by this paper
• Silencing CCAT2 inhibited proliferation and invasion of epithelial ovarian carcinoma cells by regulating Wnt signaling pathway.

  2017cited by this paper
• Dysregulated expression of long noncoding RNAs in gynecologic cancers

  2017cited by this paper
• Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.

  2017cited by this paper
• CCAT2: A novel oncogenic long non‐coding RNA in human cancers

  2017cited by this paper
• Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.

  2017cited by this paper
• Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2

  2017cited by this paper
• Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells.

  2017cited by this paper
• Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis.

  2017cited by this paper
• Global Cancer in Women: Burden and Trends

  2017cited by this paper
• Expression Study and Clinical Correlations of MYC and CCAT2 in Breast Cancer Patients

  2017cited by this paper
• RETRACTED: Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b

  2017cited by this paper
• Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway

  2017cited by this paper
• Topical oxygen therapy results in complete wound healing in diabetic foot ulcers

  2016cited by this paper
• Spheroid culture of primary hepatocytes with short fibers as a predictable in vitro model for drug screening.

  2016cited by this paper
• The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

  2016cited by this paper
• The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis

  2016cited by this paper
• Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells’ response to tamoxifen

  2016cited by this paper
• Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis

  2016influential reference
• Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss

  2016cited by this paper
• Surgical Treatment of Early l Stage Lung Cancer: What has Changed and What will Change in the Future

  2016cited by this paper
• The first investigation of Wilms' tumour atomic structure-nitrogen and carbon isotopic composition as a novel biomarker for the most individual approach in cancer disease

  2016cited by this paper
• Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity

  2016cited by this paper
• shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells

  2016cited by this paper

• No citing papers are available for this paper.